Freeman Kevin D - SEC Form 4 Insider Trading Screener
CIK: 1522478 - Address: C/o Galectin Therapeutics, Inc., 4960 Peachtree Industrial Blvd., Ste 240, Norcross, GA 30071
6 results - 
- 
- 
- 
- 
- 
- 
- - - - - - | TC | cnt | 1d | 1w | 1m | 6m |
X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2019-05-31 | GALT | Freeman Kevin D | Dir | P - Purchase | $4.28 | +9,136 | 49,179 | +23% | +$39,102 | |||||
2019-04-05 | GALT | Freeman Kevin D | Dir | P - Purchase | $4.73 | +500 | 40,043 | +1% | +$2,365 | ||||||
2019-02-08 | GALT | Freeman Kevin D | Dir | P - Purchase | $4.29 | +1,500 | 39,543 | +4% | +$6,428 | ||||||
2018-02-01 | GALT | Freeman Kevin D | Dir | P - Purchase | $4.10 | +2,000 | 38,043 | +6% | +$8,191 | ||||||
2018-02-01 | GALT | Freeman Kevin D | Dir | P - Purchase | $4.10 | +2,000 | 38,043 | +6% | +$8,191 | ||||||
2017-12-07 | GALT | Freeman Kevin D | Dir | P - Purchase | $1.63 | +8,400 | 36,043 | +30% | +$13,662 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |